Julian S Gangolli Revance Therapeutics, Inc. (RVNC) insider trading activity

Julian S Gangolli is Director of Revance Therapeutics, Inc.. Currently has a direct ownership of 45,106 shares of RVNC, which is worth approximately $115,922. The most recent transaction as insider was on May 01, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.1K

0% 3M change

49.82% 12M change

Total Value Held $115,922

Julian S Gangolli Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2024	BUY Grant, award, or other acquisition	-	15,000 Added 24.96%	45,106 Common Stock
May 03 2023	BUY Grant, award, or other acquisition	-	3,534 Added 10.51%	30,106 Common Stock
May 04 2022	BUY Grant, award, or other acquisition	-	6,059 Added 18.57%	26,572 Common Stock
May 05 2021	BUY Grant, award, or other acquisition	-	4,013 Added 16.36%	20,513 Common Stock

Also insider at

OTLK

Outlook Therapeutics, Inc. Healthcare

KRYS

Krystal Biotech, Inc. Healthcare

Director

JSG